Actions Panel
Ticket sales end soon
TEN Capital Presents Lung Cancer Diagnostics & Genomic Testing: Advantages, Disadvantages,& Challenges with Dr. Sandip Patel and Vocxi
By TEN Capital NetworkFollow
When and where
Date and time
Thursday, August 10 · 9 – 10:30am PDT
Location
Online
About this event
- 1 hour 30 minutes
- Mobile eTicket
Join TEN Capital Network for a special event about the advantages, disadvantages, and challenges of Lung Cancer Diagnostics and Genomic Testing.
Every day there are more and more cases of lung cancer being diagnosed. With the advancements in medicine and technology, there are new ways for early detection and monitoring.
Join TEN Captial Network, Dr. Sandip Patel of the University of California San Diego Health, and Vocxi for a discussion on Lung Cancer Diagnosis, personalized biomarkers for detection and monitoring, and the Next generation approaches for early detection.
Register Now: Thursday, August 10th, at 12:00 PM ET / 9 AM PT
About Dr. Sandip Patel
Sandip Patel, MD, is a board-certified medical oncologist who specializes in cancer immunotherapy and early-phase clinical trials involving immunotherapy across all types of cancer. He is focused on developing personalized therapies that stimulate a patient’s immune system to attack their specific tumor. He is part of UC San Diego Health’s Precision Immunotherapy Clinic, which offers the most promising investigational immunotherapy treatments for many types of cancer.
About Vocxi
Vocxi is a team of scientific, medical device, and diagnostic leaders who have dedicated their lives to transforming the patient trajectory. We have been quietly iterating and developing a novel technology to change the course of diagnostics into one that is accessible by all, accurate, and approachable. Headquartered in the Twin Cities of Minnesota, we reside in a nexus of medical technology companies and professionals. We are a spinout of a leading global medical device company and a world-class research university. The combined teams have brought dozens of products to market with patients around the world positively impacted. As we come out of stealth mode, we are excited to bring a transformational technology to market to reshape the patient experience that will lead to better outcomes.
Report this eventTicket sales end soon
https://www.eventbrite.com/e/lung-cancer-diagnostics-genomic-testing-tickets-681435139847
